The Atlanta type of hereditary persistence of fetal hemoglobin (HPFH) is characterized by a mild elevation of Hb F (2% to 5% in heterozygotes), almost exclusively of the ' y type (more than 90%). Gene-mapping analysis has identified this condition as a -'y-'yarrangement with the -158 (C -+ T) substitution in the promoters of both ' y genes. We have reevaluated this condition in members of two families. Sequence analysis identified only two changes in the 3'y gene as compared with the Ay gene from a chromosome with haplotype no. 3 (or Senegal), namely the -158 (C --t T) promoter mutation and the C -+ G change in codon (CD) 136, which accounts for the -Gy-Gy-phenotype. The absence of any other nucleotide (nt) substitution provides genetic HE -'y--'y-GENE arrangement is a common anomaly observed with a frequency of 4.6% among blacks.' Adults with this condition have low fetal hemoglobin (Hb F) (less than 1.3%) and high ' y (71% to 100%) values.' The same y-globin gene arrangement has been observed in two families with the Atlanta type of hereditary persistence of Hb F (HPFH).334 Heterozygotes for this condition have elevated Hb F levels of 2% to 5% that are higher in young children and in compound heterozygotes with sickle cell H Hb S.'-' The ' y values in all affected individuals exceed 90%.2 Gene-mapping analysis has shown that both ' y genes on this HPFH chromosome contain the -158 (C -+ T) change in their promoter^.^
evidence that the -158 (C --t T) change is primarily responsible for the elevated Hb F levels associated with this condition. A quantitative reverse transcriptionlpolymerase chain reaction (RT/PCR) procedure, presented in detail in this report, was developed to determine the effect of this mutation on the transcription of individual y genes in four individuals with the Atlanta type of HPFH. Both y-globin genes, ie, the (5') ' y and the (3') OrAtlanta genes of the Atlanta type of HPFH chromosome, expressed elevated amounts of transcripts, which were present in nearly equal amounts. This shows that the -158 (C -+ TI mutation exerts its effect on the transcriptional rate of the gene with which it is associated. 0 1994 by The American Society of Hematology.
cytometric analysis with an anti-Hb F monoclonal antibody showed a small increase in F-cell percentages in individuals homozygous or heterozygous for the C -+ T change at -158
To investigate the possible role of the -158 (C -+ T) substitution on y-globin gene expression in the Atlanta type of HPFH, we studied the sequences of the 5'y ('7) and 3'7 ('7-Atlanta) globin genes in four members of two families with this condition. A competitive reverse transcriptiodpolymerase chain reaction (RTPCR) method was developed to evaluate the relative amounts of the transcripts from the individual y genes in this condition.
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MATERIALS AND METHODS
Hematologic and Hb composition data.
Blood samples from three members of a previously reported family with the Atlanta type of HPFH4 and from two new cases (a 19-year-old black woman and her 2-year-old son) were collected in vacutainers with EDTA as anticoagulant and transported in ice to the laboratory. Informed consent was obtained. Three normal adults served as controls. Complete blood counts and red cell indices were obtained with an automated cell counter. The Hb F and Hb A2 were quantified by cation exchange high performance liquid chromatography (HPLC).*." The relative quantities of the ' y and Ay chains in isolated Hb F were determined by reversed phase HPLC.'2,'3 Serum ferritin levels were analyzed with the Quantimune Ferritin IRMA (Bio-Rad Laboratories, Richmond, CA).
DNA analysis. DNA was isolated from the white blood cells by the method of Poncz et al. ' 4 Gene-mapping analysis was with Bgl 11, Xmn I, and Pst I, and the y-IVS-I1 probe as previously described.5 The 5' flanking regions of the G-,-and Ayglobin genes were amplified independently with 5' oligonucleotide primers specific for (5'-ACGTCATAATCTACCAAGGTCATG-3', positions -1227 to -1204) or A-, (5'-AGCTTAGGGGATAAACTAAmc", positions -1279 to -1257) (all numbers are relative to the Cap site of the nearest y gene). A common 3' amplification primer was used (5'-GGCGTCTGGACTAGGAGCTTATTG-3', positions +53 to +30). The second intervening sequence (IVS-11) regions were amplified with a common 5' primer (5'-TGGACCCAGAGGTTCTITGA-3', positions +287 to +306), and 3' primers specific for Oy (5'-TGT-GCTGCAATCCAGGGAAGGGGGT-3', positions + I948 to + 1924) or Ay (5'-CTGCAATCAATCCAGCCCCCAGGTC-3'. positions + 1908 to + 1885). The specificity of the PCR procedures in amplifying only '7 or Ay sequences has been established in a previ--158 (Gy) PROMOTER MUTATIONS AND THE ATLANTA HPFH   3351 ous study, which also gives details of the PCR and sequencing reaction^.'^ The presence of the most common a-thal-2 determinant among blacks (the -a3"-kb deletion) was investigated with a PCRbased procedure." RNA analysis. Total cellular RNA was isolated with the procedure of Chomczynski and Sac~hi.'~ Briefly, the cells in 10 mL of freshly collected blood were washed twice with phosphate-buffered saline, centrifuged at 2,500 rpm for 10 minutes at 4"C, and the reticulocyteenriched top fraction (1 mL) was transferred into four 1.5-mL Eppendorf tubes. Five hundred microliters of solution D (4 m o m guanidinium thiocyanate, 25 m o v L sodium citrate, pH 7, 0.5% sarcosyl, and 0.1 mol/L B-mercaptoethanol) was added to each tube, followed by 50 pL of 2 mol/L sodium acetate, pH 4, 0.5 mL of acid phenol (water saturated), and 100 pL of a chloroform-isoamylalcohol mixture (49:l). After centrifugation at 10, OOOg for 20 minutes at 4"C, the RNA present in the aqueous phase was precipitated with 0.5 mL of isopropanol at -20°C for at least 1 hour, collected by centrifugation, and dissolved in 15 pL water.
Three microliters (1 to 2 pg of RNA) was reverse transcribed (RT) with an oligo-dT primer, using the Gene Amp RNA/PCR kit (Perkin Elmer-Cetus, Norwalk, CT) and the procedure recommended by the manufacturer. The entire RT sample was next subjected to PCR amplification with two oligonucleotide primers (50 pmol/L each) complementary to two regions in exon 2 and in the 3' untranslated region where the ' 7 . Ay. and '7-Atlanta globin genes have identical sequences. Their sequences and positions were: GF 5'-CTGACTTCClTGGGAGAT-3', positions +381 to +397; and GR 5"GCTTGC-AGAATAAAGCCTA-3' located from nucleotide (nt) +55 to nt +33, 3' to the termination codon (CD). The PCR was done as recommended by the manufacturer of the RNAPCR kit, except that the Taq polymerase was added during the first cycle of denaturation (95°C. 5 minutes). The PCR required 30 cycles of 1 minute of denaturation at 95T, 1 minute of annealing at 54"C, and 1 minute of extension at 72"C, in a Perkin Elmer-Cetus thermal cycler. Fifteen microliters of the PCR product were next radioactively labeled with the 3zP-labeled GF oligonucleotide primer through only one cycle of extension, which prevented the formation of "P-labeled -=~-~y -.
-'y"y-Atlanta, and -Ay-Gy-Atlanta heteroduplexes. The reaction mixture contained, besides the PCR product, 40 pmoVtube of the 32P-labeled GF oligonucleotide, 5 p L of reaction buffer (200 mmoVL 3-[N-Morpholino] propanesulfonic acid [MOPS], pH 7.8, 500 mmol/L NaCI, 30 mmol/L MgC12), 2.5 pL of 6 mmol/L deoxynucleotide triphosphate, and 2.5 U of Taq polymerase (Perkin Elmer-Cetus) in a final volume of 50 pL. The thermal cycler profile was denaturation for 5 minutes at 95"C, annealing for 2 minutes at 54°C. and extension for 12 minutes at 72°C. The GF oligonucleotide primer (800 pmoVtube) was previously labeled to high specific activity with 2 pL of "P-adenosine triphosphate (7,000 Ci/mmol/L; ICN Biochemicals, Irvine, CA) and 30 U Polynucleotide kinase (US Biochemical, Cleveland, OH)," and purified by elution through a Nick column (Pharmacia, Uppsala, Sweden). A double-restriction enzyme digestion was done on the radioactively labeled PCR product with Pst I (New England Biolabs, Beverly, MA), which recognizes only the Ay sequence at CD 136 (207 bp from the '2P-labeled oligonucleotide), and Hinf I (New England Biolabs), which cuts the Ay and the '7-Atlanta PCR products at nt position + 1502 from the Cap site (254 bp from 32P GF, Fig 1) . Four microliters of each digestion was analyzed on a nondenaturing 6% polyacrylamide gel and autoradiographed for 4 to 12 hours. The sizes of the fragments were confirmed by analyzing the remainder of the digestion on an ethidium bromide-stained 2% agarose gel with a l-kb ladder (GIBCO-BRL, Gaithersburg, MD) as a marker. Densitometric scanning of the autoradiograms was done on a Shimadzu CS4000 densitometer (Columbia, MD).
RESULTS
FamiZy W. Two members of this black family were investigated because of the high Hb F levels (26.2%) in the 2-year-old Hb S heterozygote (Table 1) . Other hematologic and Hb parameters were normal except for a mild microcytosis and hypochromia, possibly of nutritional origin. The mother had only a slightly elevated Hb F level (1.6%), almost exclusively of the ' y type (98%). The father was not available for study.
Family B. This family was studied in 1984 when six members were characterized as heterozygotes for the Atlanta type of HPFH? A 32-year-old woman (S.B.) and her two daughters (N.B. and M.B.), both with an additional Hb S heterozygosity, were reevaluated ( Table 1 ). All three had microcytosis and hypochromia, especially prominent in N.B., who was anemic (Hb 7.8 g/dL). The Hb F levels in S.B. were similar to those observed in 1984 (5.5% and 4.2%), whereas decreases from 9.8% to 5.3% and from 40% to 6.2% were observed in N.B. and M.B., respectively. The ' y values were (nearly) 100%. Decreased levels of serum femtin were present in S.B., N.B., and also in D.W. of family W (Table 1) . D.W., S.B., and M.B. were carriers of the -3.7-kb deletion (-a3.'/aa).
Globin gene mapping with Pst I for the two members of family W showed that both y genes on one chromosome have a GGA for CD 136 (glycine in the y chain), which is the only difference in the coding regions between a ' y and an * y gene. Digestion with Xmn I showed that both y gene promoters on this chromosome had the C + T change at -158. This mutation was also present in the ' y promoter of the normal chromosome in the mother (D.W.). Identical gene mapping data were previously reported for the HPFH chromosomes in family B. 4 The sequences of the 5' flanking regions (positions -591 to -l), the second introns, the third exons, and the 3' flanking regions through position +l625 of the y-globin genes were determined in two members of each family (D. (Fig 2) . Exons l and 2 and the IVS-I were not analyzed because these regions of the G y and Ay genes have identical sequences.
Analysis of the y-globin genes of D.W. showed identical sequences except for two variations in the 3' y gene, referred to as the 'y-Atlanta gene, which were located at position -158 (C and T) and in CD 136 (C and G) (Fig 2) . The sequence with C at -158 and C in CD 136 (GCA for alanine) was identical to the previously published sequence of the Ay gene from the PS chromosome with the Senegal haplotype (no. 3).15 The T at -158 creates an Xmn I site upstream of the 'y-Atlanta gene, whereas the G at CD 136 (GGA for glycine) introduces the well-known Ala 3 Gly substitution in the y chain, changing the gene from Ay to ' y . Thus, the chromosome with the Atlanta type of HPFH contains a 5' The amplified PCR fragment was labeled at the 5' end, and aliquots of this product were subjected to double digestion with Hinfl and Pst I (Fig 3) . The relative values of particular transcripts obtained by densitometric scanning of autoradiograms are presented in Table 2 . The Gy-Atlanta transcripts of HPFH and in t h m controls. The values obtained after densitometric running of the autoradiograms a n listed in Table 2 . +'y -A~I -G~ - ' 7 Two men (A.D. and E.B.) and one woman (D.P.) served as controls. were present only in the four individuals with the Atlanta type of HPFH (Fig 3) . The levels of these transcripts were equal or slightly higher than those of the ' 7 transcripts, whereas the Ay transcripts were absent (in S.B.) or below 4% ( Table 2 ). Higher levels of ' 7 than Ay transcripts were present in the three controls ( Table  2) . The values were comparable with those obtained for the ' y and Ay chains in isolated Hb F by reversed-phase HPLC. The unexpected observation of a T at -158 in the Ay promoter of the Atlanta type of HPFH chromosome provided a unique opportunity to study the effect of this mutation on the level of transcription of an Ay gene. Comparison of the levels of '7, Ay, and 3' y (='y-Atlanta) transcripts showed similar values for the ' 7 and 'y-Atlanta transcripts in three individuals with the Atlanta type of HPFH ('y, 43.9% to 48.0%; 'y-Atlanta, 51.0% to 52.6%). This ratio is similar to the 'ylAy-globin chain ratio observed in normal adults (40:60), taking into account that the ' y mRNA value includes the output of the 'y-globin gene of the second chromosome. The values for the Ay transcript in these three individuals were low (1 % to 4%) indicating a low output from the non-HPFH chromosome. No Ay transcripts were present in S.B., who had one chromosome with the Atlanta type of HPFH (+'y+'y) and a second with the common -'y-'yarrangement. Using a similar approach we have also attempted to evaluate the relative expression of the y -versus P-globin gene mRNA transcripts in the individuals with the Atlanta type of HPFH. Oligonucleotide primers complementary to two regions in exons 1 and 2, which have identical sequences in the y-and @-globin genes, have been used in the RTiPCR analysis, followed by differential digestion with restriction enzymes that recognize either y-or P-globin gene transcripts. The levels of y mRNA transcripts obtained by this approach were significantly higher than expected from the levels of Hb F observed in the individuals with the Atlanta type of HPFH, as well as in several normal controls, suggesting the preferential amplification of the y at the expense of the p mRNA transcripts. The analysis of serial dilution of cloned y and @ RTPCR fragments confirmed this observation, and we are currently investigating this phenomenon; details of these analyses will be published separately.
The quantitative R T R R procedure described here has been shown to be useful for the determination of the relative amounts of individual y mRNA transcripts, even in individuals with low Hb F levels and reticulocyte counts of less than 1 %. The '7, Ay , and 'y-Atlanta transcripts are coamplified in a single competitive PCR, followed by endonuclease digestion with restriction enzymes that recognize sequences specific for the individual transcripts. This approach has been used for the quantification of GM-CSF mRNA by comparison with serial dilutions of external competitor DNA containing a unique restriction enzyme site. 23 We have modified this approach by competing between different mRNA molecules present within the same cell. No preferential amplification can occur because the template sizes and the target sequences for the oligonucleotide primers are identical in the different transcripts. Moreover, high sequence homology between the sequences of individual transcripts exclude the possibility of preferential amplification of particular templates. A further development is the absence of -Gy-Ay-, -'y-'y-Atlanta, and -Ay-Gy-Atlanta heteroduplexes that will remain uncleaved by the restriction enzyme and will not affect the ratios of the different transcriptsz3 (and unpublished observations, 1993). The high sequence homology between the coding regions of the different globin genes allows further use of this procedure in studies pertaining to their expression. However, a possible preferential amplification of transcripts that have a high degree of sequence differences as observed, for instance, in the y and p mRNA transcripts, should be considered in evaluating the results of these experiments.
